Back to Webinars
Sharpening a Double-Edged Sword: Bispecific CAR-T Cancer Therapies

Featured Speakers: David Miklos, MD, PhD, Chief Clinical Director, Blood and Marrow Transplantation and Cellular Therapy, Cancer Cell Therapy Stanford University

What's Inside

In this Webinar we discuss:

CAR-T benefits are T cell dependent

Treatment schema for CAR-T cell therapy

Explore several case studies

awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Watch the Webinar